|
A study of the association between enzalutamide blood concentrations and adverse events in patients with castration-resistant prostate cancer. |
| |
|
Consulting or Advisory Role - Astellas Pharma; Janssen |
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Janssen; Sanofi; Takeda |
Research Funding - Astellas Pharma; Bayer |
| |
|
Research Funding - Astellas Pharma |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Speakers' Bureau - Astellas Pharma |
| |
|
No Relationships to Disclose |